Free Trial

OmniAb (OABIW) Competitors

$0.32 0.00 (0.00%)
As of 04/17/2025

OABIW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROW

Should you be buying OmniAb stock or one of its competitors? The main competitors of OmniAb include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry.

OmniAb vs.

OmniAb (NASDAQ:OABIW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, community ranking, institutional ownership, media sentiment and risk.

Company Net Margins Return on Equity Return on Assets
OmniAbN/A N/A N/A
180 Life Sciences N/A N/A N/A

OmniAb and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
OmniAbN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OmniAb$26.39MN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

In the previous week, OmniAb's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
OmniAb Neutral
180 Life Sciences Neutral

Summary

OmniAb beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get OmniAb News Delivered to You Automatically

Sign up to receive the latest news and ratings for OABIW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OABIW vs. The Competition

MetricOmniAbBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$122.22M$5.32B$7.35B
Dividend YieldN/A3.82%5.47%4.31%
P/E RatioN/A3.0521.9417.82
Price / SalesN/A4,230.36380.9497.72
Price / CashN/A13.2238.3134.64
Price / BookN/A34.746.453.98
Net IncomeN/A-$93.04M$3.22B$247.81M
7 Day Performance1.45%2.19%5.85%3.19%
1 Month Performance-19.60%-5.51%-9.58%-7.70%
1 Year Performance-38.85%85.44%11.85%1.49%

OmniAb Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OABIW
OmniAb
N/A$0.32
flat
N/AN/A$0.00$26.39M0.00106
ATNFW
180 Life Sciences
N/A$0.01
-1.4%
N/A-12.2%$0.00N/A0.007Positive News
Gap Down
SXTPW
60 Degrees Pharmaceuticals
N/A$0.04
-45.6%
N/A-50.2%$0.00$607,574.000.002Positive News
Gap Up
High Trading Volume
DRTSW
Alpha Tau Medical
N/A$0.20
-0.1%
N/AN/A$0.00N/A0.0080Gap Down
WENAW
Anew Medical
N/A$0.04
-0.3%
N/AN/A$0.00N/A0.00N/AGap Down
APLMW
Apollomics
N/A$0.01
+1.3%
N/A-61.6%$0.00N/A0.0059Short Interest ↓
Positive News
BCTXW
BriaCell Therapeutics
N/A$0.07
-21.3%
N/A-93.1%$0.00N/A0.008Positive News
Gap Up
CDIOW
Cardio Diagnostics
N/A$0.03
+0.8%
N/A-70.2%$0.00$34,890.000.007Short Interest ↑
Gap Up
CTCXW
Carmell
N/A$0.03
+6.8%
N/A-66.6%$0.00$32,839.000.0014Gap Up
CELUW
Celularity
N/A$0.04
-4.0%
N/A+1.0%$0.00$48.20M0.00220Positive News
CEROW
CERo Therapeutics
N/A$0.01
+21.7%
N/A-82.1%$0.00N/A0.008Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:OABIW) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners